MARY UDSETH: Open Payments
NPI 1922400720 · ELDERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,717 in 93 payments from 19 companies in 2025. Trend: 2023 $1,930 · 2024 $1,588 · 2025 $1,717
Food & beverage: $1,717
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $255 |
| ABBVIE INC. | 19 | $206 |
| Novo Nordisk Inc | 9 | $193 |
| Astellas Pharma US Inc | 6 | $147 |
| Amgen Inc. | 9 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $113 |
| Merck Sharp & Dohme LLC | 4 | $113 |
| Lilly USA, LLC | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Dexcom, Inc. | 3 | $67 |
Products named: JARDIANCE, Veozah, VRAYLAR, NURTEC ODT, OTEZLA, Ozempic, PREVNAR 20, CAPVAXIVE.
Industry payments across MD — which companies pay providers there.
